Lista de obras - Elena Quaglino - Dominio Público Uruguay

2H,3H-decafluoropentane-based nanodroplets: new perspectives for oxygen delivery to hypoxic cutaneous tissues

artículo científico publicado en 2015

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

artículo científico publicado en 2010

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia

artículo científico publicado en 2001

A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.

artículo científico publicado en 2005

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.

artículo científico publicado en 2000

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

artículo científico publicado en 2015

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer

artículo científico publicado en 2015

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

scientific article published on 29 May 2014

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

artículo científico publicado en 2014

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

scientific article published on 10 August 2011

Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

article

Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues

artículo científico publicado en 2015

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice

artículo científico publicado en 2007

DNA vaccination against oncoantigens: A promise

artículo científico publicado en 2012

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

scientific article published on 12 September 2013

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

artículo científico publicado en 2004

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

artículo científico publicado en 2011

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

artículo científico publicado en 2013

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

artículo científico publicado en 2005

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

scientific article published on 06 April 2020

Immunological prevention of spontaneous tumors: a new prospect?

scientific article published on 01 February 2002

Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.

artículo científico publicado en 2001

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

artículo científico publicado en 2001

Interleukin 12-activated lymphocytes influence tumor genetic programs

artículo científico publicado en 2001

Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells

artículo científico publicado en 2012

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

artículo científico publicado en 2014

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

artículo científico publicado en 2003

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

article by Raffaele A. Calogero et al published 20 February 2008 in Cancer Immunology, Immunotherapy

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity

artículo científico publicado en 2016

Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain.

artículo científico publicado en 2008

Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013

article

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

artículo científico publicado en 2018

The Promise of Preventive Cancer Vaccines

artículo científico publicado en 2015

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.

artículo científico publicado en 2005

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

artículo científico publicado en 2016

The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2(+) mammary cancer.

artículo científico publicado en 2015

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

artículo científico publicado en 2014

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

artículo científico publicado en 2010

miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

artículo científico publicado en 2013

miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.

artículo científico publicado en 2013

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

artículo científico publicado en 2012

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.

artículo científico publicado en 2011

Lista de obras de Elena Quaglino

2H,3H-decafluoropentane-based nanodroplets: new perspectives for oxygen delivery to hypoxic cutaneous tissues

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia

A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice

DNA vaccination against oncoantigens: A promise

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

Immunological prevention of spontaneous tumors: a new prospect?

Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

Interleukin 12-activated lymphocytes influence tumor genetic programs

Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity

Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain.

Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

The Promise of Preventive Cancer Vaccines

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2(+) mammary cancer.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.